Research

Hyperbaric Research Library: Studies by Pressure and Protocol

Hyperbaric research is a dosing question. A study's result only makes sense alongside its pressure, breathing gas, session length, and schedule. This library lists peer-reviewed studies with each of those details stated, links every study to its source, and includes mild-pressure research and null results.

How to read a hyperbaric study

Hyperbaric therapy means breathing inside an environment pressurized above normal atmospheric pressure. Pressure and oxygen concentration are separate variables, and the delivered dose also depends on session length, frequency, and total sessions. For each study below, look at five things first:

  • Pressure, in ATA
  • Breathing gas: room air, enriched oxygen, or near 100% oxygen
  • Minutes at pressure per session
  • Schedule: sessions per week and total sessions
  • Comparator: sham exposure, no treatment, or none

Then check who was studied and what was measured. A change in a blood marker is not the same as a clinical outcome, and a result in one population does not carry over to another.

Studies

Showing 7 of 7 studies.

Stem and progenitor cells | Prospective single-arm study

Hyperbaric air mobilizes stem cells in humans; a new perspective on the hormetic dose curve

MacLaughlin KJ, et al. Frontiers in Neurology, 2023. doi:10.3389/fneur.2023.1192793

Population
10 healthy volunteers aged 34 to 35
Pressure
1.27 ATA (4 psig)
Breathing gas
Room air
Session length
90 minutes
Schedule
Monday to Friday, 10 exposures over 2 weeks
Comparator
Each participant served as their own control (blood drawn before the first exposure)

What the authors reported: The authors measured mobilization of stem and progenitor cells and changes in cytokines in blood samples after hyperbaric air exposures.

Limits to keep in mind: Ten participants and no separate control group. The endpoint is circulating cell counts, which is not the same as tissue regeneration or a clinical benefit.

Mild traumatic brain injury | Randomized crossover trial

Hyperbaric Oxygen Therapy Can Improve Post Concussion Syndrome Years after Mild Traumatic Brain Injury - Randomized Prospective Trial

Boussi-Gross R, et al. PLOS ONE, 2013. doi:10.1371/journal.pone.0079995

Population
56 patients with mild traumatic brain injury, 1 to 5 years after injury, with prolonged post-concussion syndrome
Pressure
1.5 ATA
Breathing gas
100% oxygen
Session length
60 minutes
Schedule
5 days per week, 40 sessions
Comparator
A 2-month control period with no treatment (crossover design)

What the authors reported: The authors reported improvements in brain function measures and quality of life after the treatment period, and concluded that the protocol can induce neuroplasticity in this population.

Limits to keep in mind: The control condition was no treatment, not a sham exposure, so participants knew when they were being treated.

Mild traumatic brain injury | Randomized controlled trial

Effects of Hyperbaric Oxygen on Symptoms and Quality of Life Among Service Members With Persistent Postconcussion Symptoms: A Randomized Clinical Trial

Miller RS, et al. JAMA Internal Medicine, 2015. doi:10.1001/jamainternmed.2014.5479

Population
72 military service members with persistent post-concussion symptoms
Pressure
1.5 ATA
Breathing gas
100% oxygen delivered by a hood
Session length
60 minutes
Schedule
Weekdays, 40 sessions
Comparator
Sham sessions of room air at 1.2 ATA, and a third group with no chamber sessions

What the authors reported: No difference was observed between the oxygen group and the sham group. Both chamber groups showed more symptom improvement than the group that received routine care alone. The authors concluded that oxygen showed no benefit over sham compressions.

Limits to keep in mind: The sham arm was itself a pressurized exposure (room air at 1.2 ATA), so the trial compared two pressurized conditions. Read alongside the trial above, it shows why protocols must be compared by dose and control condition, not by name.

Stroke | Randomized controlled trial

Hyperbaric Oxygen Induces Late Neuroplasticity in Post Stroke Patients - Randomized, Prospective Trial

Efrati S, et al. PLOS ONE, 2013. doi:10.1371/journal.pone.0053716

Population
74 post-stroke patients enrolled (15 were excluded)
Pressure
2 ATA
Breathing gas
100% oxygen
Session length
90 minutes
Schedule
5 days per week, 40 sessions over 2 months
Comparator
A 2-month control period with no treatment

What the authors reported: The authors reported neurological improvements after the treatment period in patients at chronic late stages after stroke.

Limits to keep in mind: The control condition was no treatment, not a sham exposure.

Post-COVID condition | Randomized controlled trial

Hyperbaric oxygen therapy improves neurocognitive functions and symptoms of post-COVID condition: randomized controlled trial

Zilberman-Itskovich S, et al. Scientific Reports, 2022. doi:10.1038/s41598-022-15565-0

Population
73 patients with post-COVID condition (37 treatment, 36 sham)
Pressure
2 ATA
Breathing gas
100% oxygen by mask, with 5-minute air breaks every 20 minutes
Session length
90 minutes
Schedule
5 sessions per week, 40 sessions over 2 months
Comparator
Sham: 21% oxygen by mask at 1.03 ATA for 90 minutes

What the authors reported: In this sham-controlled, double-blind trial, the authors reported improvements in cognitive, psychiatric, fatigue, sleep, and pain symptoms in the treatment group compared with sham.

Limits to keep in mind: A single-center trial. This research does not mean an OxyHealth chamber is cleared for this use.

Healthy aging | Randomized controlled trial

Cognitive enhancement of healthy older adults using hyperbaric oxygen: a randomized controlled trial

Hadanny A, et al. Aging, 2020. doi:10.18632/aging.103571

Population
63 healthy adults older than 64
Pressure
2 ATA
Breathing gas
100% oxygen by mask, with 5-minute air breaks every 20 minutes
Session length
90 minutes
Schedule
5 sessions per week, 60 sessions over 3 months
Comparator
A control arm of 30 participants (no sham exposure described in the abstract)

What the authors reported: The authors reported a significant group-by-time interaction in global cognitive function after the treatment period compared with control (p=0.0017).

Limits to keep in mind: Healthy older adults only. Findings should not be extended to other populations.

Healthy aging | Prospective single-arm study

Hyperbaric oxygen therapy increases telomere length and decreases immunosenescence in isolated blood cells: a prospective trial

Hachmo Y, et al. Aging, 2020. doi:10.18632/aging.202188

Population
35 healthy, independently living adults aged 64 and older
Pressure
2 ATA
Breathing gas
100% oxygen by mask, with 5-minute air breaks every 20 minutes
Session length
90 minutes
Schedule
5 sessions per week, 60 sessions over 3 months
Comparator
None. The authors list the lack of a control group as a limitation.

What the authors reported: The authors reported that telomere length in several types of isolated blood cells increased by more than 20% and that the number of senescent T helper cells decreased after the exposures.

Limits to keep in mind: No control group. The endpoints are laboratory measures in blood cells, not clinical outcomes such as lifespan or disease.

Study protocols are not recommendations

The pressures, gases, and session counts listed here describe what researchers did in each study. They are not instructions for any individual. A qualified clinician determines whether hyperbaric therapy is appropriate and sets the breathing gas, pressure, duration, and frequency.

Several of these studies involve conditions outside the cleared indications for hyperbaric chambers. That research does not mean an OxyHealth chamber is cleared for those uses. For the difference between device clearance and clinical use, see what FDA clearance means.

Hyperbaric Research FAQ

Why do hyperbaric studies seem to disagree?

Often because they did not test the same thing. Studies differ in pressure, breathing gas, session length, number of sessions, population, endpoint, and control condition. Compare those details before concluding that the research is mixed.

Is there research on mild hyperbaric pressure such as 1.3 ATA?

Yes. Published studies have used pressures of about 1.3 ATA, including a randomized controlled trial at 1.3 atm with 24% oxygen and a study of hyperbaric air at 1.27 ATA. Each should be read by its exact protocol and population.

Does this research mean a chamber is cleared to treat these conditions?

No. Research on a condition is not the same as a device being cleared for that use. FDA clearance concerns the device and its cleared labeling. How a physician uses a cleared device is a separate medical judgment.

How are studies chosen for this library?

Each study is peer reviewed and was checked against the publisher's own article page for its title, design, sample size, protocol, and reported finding. The list includes mild-pressure studies and a trial that found no difference between groups.

Learn how chamber types differ

Portable soft-sided chambers and clinical hard-sided chambers operate at different pressures and are built for different settings. Protocol choices belong to a qualified clinician.